Point72 Asset Management
AMRX icon

Point72 Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Point72 Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78,105
Closed -$971K – 3966
2026
Q1 		$971K Buy
+78,105
New +$1.05M ﹤0.01% 2775
2025
Q2 		– Sell
-446,000
Closed -$3.74M – 2151
2025
Q1 		$3.74M Buy
+446,000
New +$3.72M 0.01% 1040
2024
Q2 		– Sell
-60,500
Closed -$367K – 1832
2024
Q1 		$367K Buy
+60,500
New +$341K ﹤0.01% 1721
2023
Q4 		– Sell
-124,000
Closed -$523K – 2129
2023
Q3 		$523K Buy
+124,000
New +$462K ﹤0.01% 1498
2022
Q4 		– Sell
-2,750,000
Closed -$5.55M – 1497
2022
Q3 		$5.55M Sell
2,750,000
-714,900
-21% -$2M 0.02% 686
2022
Q2 		$11M Buy
3,464,900
+466,020
+16% +$1.69M 0.05% 489
2022
Q1 		$12.5M Sell
2,998,880
-312,520
-9% -$1.38M 0.05% 450
2021
Q4 		$15.9M Sell
3,311,400
-433,600
-12% -$2.16M 0.06% 391
2021
Q3 		$20M Buy
3,745,000
+1,920,196
+105% +$9.67M 0.09% 307
2021
Q2 		$9.34M Sell
1,824,804
-1,107,096
-38% -$6.29M 0.04% 469
2021
Q1 		$19.7M Buy
+2,931,900
New +$16.2M 0.09% 267
2019
Q4 		– Sell
-1,011,800
Closed -$2.93M – 938
2019
Q3 		$2.93M Sell
1,011,800
-2,303,660
-69% -$8.04M 0.02% 540
2019
Q2 		$23.8M Buy
+3,315,460
New +$33.9M 0.12% 211
2018
Q4 		– Sell
-800,000
Closed -$17.8M – 943
2018
Q3 		$17.8M Buy
+800,000
New +$16.8M 0.07% 330

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Point72 Asset Management's AMRX Position: Q2 2026 in Review

Point72 Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 78,105 shares — an estimated $971K sold.

Point72 Asset Management first reported a position in AMRX in Q3 2018 and held it in 14 quarters. The position peaked at $23.8M in Q2 2019. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Point72 Asset Management reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 78,105 Amneal Pharmaceuticals shares in Q2 2026, an estimated $971K.
  • Point72 Asset Management first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 14 quarters.
  • Point72 Asset Management's Amneal Pharmaceuticals position peaked at $23.8M in Q2 2019.
  • 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.